+1 888-880-9539Search News by Tag: oncology
370 news stories found
Press Release
May 27, 2026
Creative Biolabs today announced a strategic enhancement to its multi-omics portfolio, focusing on precision NGS solutions optimized for 3D cell cultures, spheroids, and organoids.
Read Press Release
Press Release
May 22, 2026
In a World Racing Toward Net-Zero, Researchers Propose Turning the Most Controversial Crop on Earth Into the Most Valuable One
Read Press Release
Press Release
May 22, 2026
Creative Biolabs, a premier biotechnology company specializing in ADC development, today announced the launch of its expanded "Precision Evolution" platform.
Read Press Release
Press Release
May 20, 2026
Creative Biolabs Advances Oncology Precision with Enhanced Liquid Biopsy and ctDNA Sequencing Suites
Creative Biolabs, a global leader in providing sophisticated sequencing and biological solutions, today announced the strategic expansion of its SuPrecision™ platform.
Read Press Release
Press Release
May 5, 2026
Dr. Scott Kamelle Scholarship for Future Doctors Launches National Initiative to Support Aspiring Medical Leaders Through Academic Excellence and Innovation
Read Press Release
Press Release
April 25, 2026
Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs).
Read Press Release
Press Release
April 25, 2026
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.
Read Press Release
Press Release
April 24, 2026
Creative Biolabs announced the launch of its enhanced lipid nanoparticle (LNP) conjugation platform—solving long‑standing challenges in nucleic acid delivery for gene therapy and RNA‑based therapeutics.
Read Press Release
Press Release
April 22, 2026
Creative Biolabs, a global leader in antibody engineering, has announced the expansion of its integrated suite of solutions focused on antibody-dependent cellular cytotoxicity (ADCC).
Read Press Release
Press Release
April 18, 2026
Breast cancer special issue spotlights AI while widening the view of precision care
Read Press Release
Press Release
April 17, 2026
Creative Biolabs, a global leader in recombinant antibody technology, has announced the expansion of its antibody-based active targeting system development services.
Read Press Release
Press Release
April 16, 2026
Creative Bioarray announced the release of its cutting-edge solutions powered by patient-derived organoid technology
Read Press Release
Press Release
April 15, 2026
US Fertility has been recognized by Castle Connolly as the #1 physician practice nationally for most Top Doctors in Reproductive Medicine Care and the #1 physician practice nationally for most Top Doctors in Women's Health Care.
Read Press Release
Press Release
April 1, 2026
Nassir Mansour, MD, MRCS, FAANS, has been named a 2026 Castle Connolly Top Doctor, the first year he has received the esteemed Top Doctor designation.
Read Press Release
Press Release
March 31, 2026
Alfa Cytology provides in vivo research support for tumor studies and immunotherapy using cancer animal models and humanized immune system mice.
Read Press Release
Press Release
March 28, 2026
Physician, Clinical Researcher, and Healthcare Executive Nitun Ahir Announces Merit-Based Award for Students Driving Innovation in Patient-Centered Care
Read Press Release
Press Release
March 27, 2026
Creative Biolabs has announced the expansion of its integrated bispecific antibody development services, setting a new benchmark for complexity and precision in next-generation immunotherapy.
Read Press Release
Press Release
March 13, 2026
Creative Biolabs, a leading global biotechnology service provider, today detailed its expanded technological capabilities in non-vaccine mRNA applications.
Read Press Release